WO2007092930A3 - Method of treatment for mycobacterium tuberculosis - Google Patents
Method of treatment for mycobacterium tuberculosis Download PDFInfo
- Publication number
- WO2007092930A3 WO2007092930A3 PCT/US2007/061859 US2007061859W WO2007092930A3 WO 2007092930 A3 WO2007092930 A3 WO 2007092930A3 US 2007061859 W US2007061859 W US 2007061859W WO 2007092930 A3 WO2007092930 A3 WO 2007092930A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mycobacterium tuberculosis
- treatment
- administering
- subject
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
Abstract
A method for treating Mycobacterium tuberculosis infections in a subject in need thereof comprising administering a naphthylamine sulfonate derivative or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77149406P | 2006-02-08 | 2006-02-08 | |
US60/771,494 | 2006-02-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007092930A2 WO2007092930A2 (en) | 2007-08-16 |
WO2007092930A3 true WO2007092930A3 (en) | 2007-12-13 |
Family
ID=38345957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/061859 WO2007092930A2 (en) | 2006-02-08 | 2007-02-08 | Method of treatment for mycobacterium tuberculosis |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007092930A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4827986B2 (en) | 2007-06-08 | 2011-11-30 | マンカインド コーポレ−ション | IRE-1α inhibitor |
WO2009091324A1 (en) * | 2008-01-14 | 2009-07-23 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3285905A (en) * | 1963-08-30 | 1966-11-15 | Parke Davis & Co | 1-{3-{[5, 6, 7, 8-tetrahydro-4-(arylazo)-1-naphthyl]amino}propyl}piperidine compounds |
US5231170A (en) * | 1986-08-27 | 1993-07-27 | Paul Averback | Antibodies to dense microspheres |
US20040131568A1 (en) * | 2002-01-29 | 2004-07-08 | Hwang Cheng Shine | Reduction of hair growth |
-
2007
- 2007-02-08 WO PCT/US2007/061859 patent/WO2007092930A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3285905A (en) * | 1963-08-30 | 1966-11-15 | Parke Davis & Co | 1-{3-{[5, 6, 7, 8-tetrahydro-4-(arylazo)-1-naphthyl]amino}propyl}piperidine compounds |
US5231170A (en) * | 1986-08-27 | 1993-07-27 | Paul Averback | Antibodies to dense microspheres |
US20040131568A1 (en) * | 2002-01-29 | 2004-07-08 | Hwang Cheng Shine | Reduction of hair growth |
Non-Patent Citations (1)
Title |
---|
GAGO G. ET AL.: "Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis", JOURNAL OF BACTERIOLOGY, vol. 188, no. 2, June 2006 (2006-06-01), pages 477 - 486, XP008091424 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007092930A2 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007087395A3 (en) | UNSATURATED mTOR INHIBITORS | |
IL186452A0 (en) | Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease | |
AP2327A (en) | Quinoline derivatives for the treatment of latent tuberculosis. | |
ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
WO2007034188A3 (en) | Chemo-immunotherapy method | |
WO2007087431A3 (en) | Sublingual fentanyl spray | |
WO2007106537A3 (en) | Aminoquinolones as gsk-3 inhibitors | |
AU2005209854A1 (en) | Method of treating hemolytic disease | |
IL192150A0 (en) | Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease | |
WO2008137237A3 (en) | Method for forming crystallized therapeutic agents on a medical device | |
WO2007087204A3 (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia | |
IL196697A (en) | Use of 4-hydroxy-alpha-phenyl butyl nitrone or its derivatives for the preparation of a medicament for treating sensorineural hearing loss | |
WO2007118130A3 (en) | Antibacterial agents | |
WO2009035634A3 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors | |
WO2007140317A3 (en) | Use of inhibitors of cytosolic ph0sph0lipase a2 in the treatment of thrombosis | |
EA201000039A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING SOLIFENACIN OR ITS PHARMACEUTICALLY ADAPTABLE SALT | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
WO2008071961A8 (en) | 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents | |
TW200733963A (en) | Cough inhibitor | |
WO2008057196A3 (en) | Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases | |
TNSN07038A1 (en) | Methods for improving bioavailability of a renin inhibitor | |
WO2008063847A3 (en) | Method for treating autism | |
WO2007092930A3 (en) | Method of treatment for mycobacterium tuberculosis | |
MX2008010804A (en) | Rapamycin derivatives for treating neuroblastoma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07763518 Country of ref document: EP Kind code of ref document: A2 |